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ABSTRACT Homeostatic maintenance of cellular mitochondria requires a dynamic balance 
between fission and fusion, and controlled changes in morphology are important for pro-
cesses such as apoptosis and cellular division. Interphase mitochondria have been described 
as an interconnected network that fragments as cells enter mitosis, and this mitotic mitochon-
drial fragmentation is known to be regulated by the dynamin-related GTPase Drp1 (dynamin-
related protein 1), a key component of the mitochondrial division machinery. Loss of Drp1 
function and the subsequent failure of mitochondrial division during mitosis lead to incom-
plete cytokinesis and the unequal distribution of mitochondria into daughter cells. During 
mitotic exit and interphase, the mitochondrial network reforms. Here we demonstrate that 
changes in mitochondrial dynamics as cells exit mitosis are driven in part through ubiquityla-
tion of Drp1, catalyzed by the APC/CCdh1 (anaphase-promoting complex/cyclosome and its 
coactivator Cdh1) E3 ubiquitin ligase complex. Importantly, inhibition of Cdh1-mediated 
Drp1 ubiquitylation and proteasomal degradation during interphase prevents the normal G1 
phase regrowth of mitochondrial networks following cell division.
INTRODUCTION
Through posttranslational modifications of mitochondrial mor-
phology–controlling proteins like (dynamin-related protein 1) 
Drp1, mitochondrial fission and fusion are coordinated with key 
cellular events (reviewed in Benard and Karbowski, 2009). Phos-
phorylation, sumoylation, nitrosylation, and ubiquitylation have 
been reported to affect various aspects of Drp1 function, including 
its localization, stability, and GTPase activity (Harder et al., 2004; 
Chang and Blackstone, 2007; Cribbs and Strack, 2007; Karbowski 
et al., 2007; Taguchi et al., 2007; Wasiak et al., 2007; Han et al., 
2008; Cho et al., 2009; Zunino et al., 2009). The yeast mitofusin 
homologue Fzo1p undergoes proteasomal degradation, and in-
creasing evidence supports a role for mammalian E3 ubiquitin li-
gases in the regulation of mitochondrial fission and fusion as well 
(Fritz et al., 2003; Escobar-Henriques et al., 2006; Nakamura et al., 
2006; Yonashiro et al., 2006; Neutzner et al., 2008; Amiott et al., 
2009; Park et al., 2010).
During the cell cycle, Drp1-mediated mitochondrial fission is 
essential for the completion of cytokinesis and for the proper dis-
tribution of mitochondria into the daughter cells (Labrousse 
et al., 1999; Okamoto and Shaw, 2005; Taguchi et al., 2007; 
Ishihara et al., 2009). In interphase cells, mitochondria have been 
described as an interconnected network that begins to fragment 
as the cells enter mitosis (Barni et al., 1996; Margineantu et al., 
2002; Taguchi et al., 2007). Mitochondrial fragmentation at the 
time of mitotic entry is known to be regulated by Cdk1/cyclin 
B-mediated phosphorylation and SenP5-mediated deSUMOyla-
tion of Drp1 (Taguchi et al., 2007; Zunino et al., 2009). During 
telophase and cytokinesis of mitotic exit, reestablishment of the 
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RESULTS
Drp1 levels decrease upon release from mitotic arrest
We examined the stability of Drp1 during cell-cycle progression and 
found that Drp1 levels dropped when cells were released from a 
nocodazole-induced prometaphase arrest, as the cells exited mito-
sis and entered G1 (Figure 1, A and B). Additionally, levels of Drp1 
gradually increased as HeLa cells entered mitosis following release 
from a double thymidine block (G1/S arrest), whereas levels of sev-
eral other proteins involved in the regulation of mitochondrial mor-
phology did not change (Figure 1, C and D). We noted that this 
down-regulation of Drp1 temporally coincides with the return of mi-
tochondria to a reticular network from their predominantly frag-
mented mitotic morphology (Supplemental Movie S1). Additionally, 
we found that in vitro–translated 35S-Drp1 was degraded in cell ex-
tracts prepared from synchronized G1 cells, whereas Drp1 was sta-
ble in lysates prepared from prometaphase-arrested cells (Figure 1, 
E and F).
In an in vitro mitotic exit assay, Drp1 protein levels decreased, 
whereas blocking mitotic exit with addition of the APC/C inhibi-
tory protein Emi2 attenuated Drp1 degradation (Figure 2A). 
occurs, and interphase mitochondria once again form an exten-
sive network (Taguchi et al., 2007; Mitra et al., 2009). Significant 
increases in mitochondrial membrane potential and respiration 
occur during progression through G1, and the presence of a hy-
perfused mitochondrial network is necessary for cyclin E accumu-
lation and cell-cycle progression (Taguchi et al., 2007; Schieke 
et al., 2008; Mitra et al., 2009).
Given the dramatic shift in morphology from fragmented mito-
chondria in mitosis to a predominantly elongated mitochondrial 
network during interphase, we wanted to determine whether al-
terations in Drp1 also contributed to changes in mitochondrial 
morphology as cells exited mitosis and entered G1. On the basis 
of the importance of ubiquitin-dependent degradation in coordi-
nating key cell-cycle transitions, we questioned whether the dra-
matic changes in mitochondrial morphology that occur as cells 
undergo division are regulated by proteolytic degradation of Drp1. 
We show here that this is, indeed, the case and that cell-cycle–
dependent degradation depends on the anaphase-promoting 
complex/cyclosome (APC/C), a central coordinator of events at 
the M/G1 transition.
FIGURE 1: Stability of Drp1 changes during the cell cycle. (A) Prometaphase-arrested HeLa cells were collected at the 
indicated times after nocodazole release. Actin is shown as a loading control, and phospho-Histone H3 is a mitotic 
marker. (B) Quantification of data shown in (A), n = 3. Drp1 protein levels were quantified and normalized to actin levels 
in three independent experiments. The results are plotted as a percentage of Drp1 remaining at 3, 5, and 7 h following 
release from nocodazole arrest, with 100% representing the Drp1 level at time 0. The error bars reflect the SE of the 
mean. (C) HeLa S3 cells were released from thymidine-induced G1/S arrest into medium containing nocodazole and 
were collected at the indicated times. (D) HeLa cells were released from thymidine-induced G1/S arrest as in (C), and 
lysates were probed for the indicated mitochondrial morphology proteins. (E) Autoradiograms of 35S-labeled Drp1 after 
incubation with HeLa cell extracts prepared 2 h after release from nocodazole arrest, or from HeLa cells arrested in 
prometaphase with nocodazole. (F) Quantification of data shown in (E), n = 5. Differences in the percentage of 35S-Drp1 
remaining in G1 lysates vs. the mitotic lysates at time points 60 and 120 min are statistically significant by Student’s t 
test (*p = 0.013079; **p = 0.013553).
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Drp1 D-Box contributes to APC/CCdh1-mediated 
ubiquitylation and degradation
To examine the contribution of the putative Drp1 D-Box to Drp1 
degradation by APC/CCdh1, we performed in vitro ubiquitylation 
assays using wild-type (WT) Drp1 or a Drp1 in which two key D-box 
residues had been mutated to alanines (RxxL to AxxA). When sup-
plemented with recombinant Cdh1 (but not Cdc20), APC com-
plexes immunoprecipitated from interphase extracts prepared 
from Xenopus eggs (a rich source of APC components) promoted 
polyubiquitylation of WT Drp1, whereas ubiquitylation of Drp1 
containing a mutant D-Box motif was attenuated, but not 
completely abolished (Figure 4, A and B; see more in HeLa cells). 
We next compared the expression of Drp1 WT to the Drp1 D-Box 
mutant during G1 phase and found that the amount of D-Box mu-
tant protein remaining after release from nocodazole arrest was 
increased relative to the WT protein (Figure 4C). Although levels of 
the D-Box mutant were stabilized during G1 relative to the WT 
protein, partial degradation of the D-Box mutant still occurred, 
suggesting that additional APC targeting motifs may be required 
for full degradation, as is the case for other for APC/CCdh1 
substrates, such as Claspin and Aurora A (Crane et al., 2004; 
Bassermann et al., 2008).
Although the D-Box that we initially identified most closely aligns 
with the canonical motif (R-X-X-L-X-X-X-X-N/D/E), upon close ex-
amination of the Drp1 protein sequence, we noted that it contains 
several previously described degrons for APC/C substrates, includ-
ing nine canonical RxxL motifs as well as noncanonical, motifs such 
as a GxEN box and an O-Box (Castro et al., 2003; Araki et al., 2005), 
and it is likely that multiple degrons are necessary for full Drp1 deg-
radation by APC/CCdh1.
Because even moderate overexpression of WT Drp1 alone is suf-
ficient to induce mitochondrial fragmentation, we anticipated that it 
On the basis of the timing of Drp1 degradation and the ability of 
Emi2 to interfere with this degradation, we examined the possi-
bility that Drp1 might be ubiquitylated by the APC/C ubiquitin 
ligase, an E3 complex active during mitotic exit and the G1 
phase of the cell cycle. In this regard, we were interested to find 
that Drp1 contains multiple APC/C degradation motifs, includ-
ing a canonical degradation box (D-Box) motif (R-X-X-L-X-X-X-X-
N/D/E), suggesting that it might be a substrate of the APC/C 
(Figure 2B).
Drp1 is a novel substrate of APC/C
Drp1 levels are lowest during the G1 phase of the cell cycle, 
when the APC/C is active through its association with Cdh1. We 
examined the effect of overexpression of the APC/C coactivator 
proteins Cdc20 and Cdh1 on Drp1 levels and found that Cdh1 
expression resulted in a significant decrease in steady-state levels 
of Drp1 (Figure 2C). Importantly, this decrease in Drp1 was at-
tenuated by treatment with the proteasome inhibitor MG132, 
and we detected binding between Drp1 and Cdh1 in cell lysates 
(Figure 2D).
On the basis of the role of Drp1 in mediating fission of mito-
chondria, we examined mitochondrial morphology in cells overex-
pressing Cdh1 and found that overexpression of Cdh1 results in a 
range of alterations in mitochondrial morphology that are consis-
tent with increased mitochondrial connectivity, stemming from ei-
ther decreased mitochondrial fission or increased mitochondrial fu-
sion (Figures 3A and Supplemental Figure 1). Indeed, when we 
measured the rate of mitochondrial fusion using diffusion of photo-
activatable mito-green fluorescent protein (mito-GFP), we observed 
a more rapid diffusion of GFP in cells expressing Cdh1 compared 
with vector control, consistent with decreased mitochondrial fission 
and increased mitochondrial fusion (Figure 3B).
FIGURE 2: Drp1 degradation is stimulated by Cdh1. (A) HeLa cells were arrested with nocodazole and then cultured in 
fresh medium for 1 h. Hypotonic cell lysates were incubated at room temperature, and aliquots were taken at the 
indicated times for immunoblotting. In the bottom panel, MBP-Emi2 was added to cell lysates before incubation at 
room temperature. (B) Alignment of D-Boxes in Drp1 and cyclin B1. (C) Expression of FLAG-tagged Drp1 with or 
without HA-Cdh1 or HA-Cdc20 in HEK 293T cells, in the absence or presence of the proteasome inhibitor MG132.  
(D) Ni-beads or Ni-beads conjugated to His-tagged Drp1 were incubated with HEK 293T cell lysates, and the beads 
were immunoblotted for Cdh1. The input lane represents 10% of the lysate used in the pull down.
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fragmentation (in contrast to other known mutations within this do-
main of Drp1, which have a dominant-negative effect and actually 
block mitochondrial fission) (Waterham et al., 2007).
We do consistently see increased expression of the D-Box mu-
tant relative to the WT in overexpression experiments, and we see 
decreased ubiquitylation of the D-Box mutant, all consistent with an 
overall increase of the D-Box mutant protein relative to the WT. We 
believe, however, that expression of the WT protein (at levels com-
parable to the D-Box mutant protein) results in a comparable de-
gree of mitochondrial fission. Thus the WT and D-Box mutants do 
not have inherently different biological activities. Rather, because 
they have different stabilities, and because mitochondrial fragmen-
tation correlates with the levels of intracellular Drp1, phenotypic dif-
ferences between WT and mutant proteins reflect their different 
abundance. Therefore, to further delineate the functional role of 
Cdh1-mediated Drp1 degradation, we wanted to investigate the 
effects of Cdh1-mediated Drp1 degradation in a Cdh1 loss-of-func-
tion context, as a more accurate way of addressing the physiological 
relevance of this degradation event.
Cdh1 regulates Drp1-dependent changes in mitochondrial 
morphology and metabolism during interphase
Consistent with a role for APC/CCdh1 in the degradation of Drp1, we 
detected elevated Drp1 protein levels in mouse embryonic fibro-
blasts (MEFs) generated from a Cdh1-null mouse, as has been re-
ported for other Cdh1 substrates (Figure 5A) (Garcia-Higuera et al., 
2008; Li et al., 2008). Moreover, when we immunoprecipitated Drp1 
from either Cdh1 +/+ or –/– asynchronous MEF cell lysates, we 
noted a decrease in Drp1 ubiquitylation in the absence of Cdh1 
(although some ubiquitylation still occurred, consistent with previ-
ous reports of other E3 ubiquitin ligases targeting Drp1) (Figure 5B) 
(Nakamura et al., 2006; Yonashiro et al., 2006; Karbowski et al., 
2007). We next compared levels of Drp1 protein during G1 phase in 
cell lysates generated from either the Cdh1+/+ MEFS versus the 
Cdh1–/– MEFs, and we found that the amount of Drp1 protein re-
maining in the Cdh1–/– cell lysates after release from nocodazole 
arrest was increased relative to the WT Cdh1+/+ MEF lysates (Figure 
5C). Together, these data demonstrate that Drp1 ubiquitylation and 
degradation is decreased in the absence of Cdh1.
On the basis of our observation that overexpression of Cdh1 
decreases Drp1 protein levels and promotes a more interconnected 
mitochondrial network, we wished to investigate the effects on 
mitochondrial morphology and function of an acute knockdown of 
Cdh1 in synchronized cells. Accordingly, we silenced Cdh1 expres-
sion, and then we examined mitochondrial morphology in a popula-
tion of HeLa cells arrested at the G1/S border. During this point in 
the cell cycle, mitochondria normally form an elongated network, as 
we saw in our scrambled control RNAi. RNAi-mediated silencing of 
Cdh1 resulted in the predominance of short, punctate mitochondria 
(Figure 6A, top panels). This mitochondrial fragmentation induced 
by Cdh1 RNAi was dependent on Drp1, as knocking down both 
Cdh1 and Drp1 attenuated this effect (Figure 6A, bottom panels; 
quantified in Figure 6B).
On the basis of the recent report from Lippincott-Schwartz and 
colleagues that a hyperfused mitochondrial state at G1/S regulates 
cyclin E accumulation, we tested whether the acute knockdown of 
Cdh1 (and the resulting mitochondrial fragmentation) would conse-
quently decrease levels of cyclin E (Mitra et al., 2009). Indeed, we 
saw a decrease in cyclin E levels in Cdh1-RNAi cells relative to RNAi 
control cells both in early G1 cells (Figure 6C) and in cells arrested at 
G1/S (unpublished data). Importantly, this decrease was attenuated 
in the presence of the double Cdh1/Drp1 knockdown, suggesting 
would be difficult to distinguish differences in degrees of mitochon-
drial fragmentation in cells overexpressing the WT Drp1 versus the 
Drp1 D-Box mutant (Labrousse et al., 1999; Szabadkai et al., 2004; 
Jagasia et al., 2005). In other words, it seems that the APC/C is not 
sufficiently active against Drp1 to cope with overexpressed Drp1, 
leaving levels of Drp1 sufficient to induce mitochondrial fragmenta-
tion. Indeed, when we examined asynchronous cells that had been 
transfected with low levels of plasmid encoding either a Drp1 WT 
(FLAG)-tagged construct or a Drp1 D-Box mutant FLAG construct, 
we observed significant mitochondrial fragmentation with expres-
sion of both the WT and D-Box mutant constructs. When mitochon-
drial morphology was examined in early G1 cells, the expression of 
either construct (at approximately equal levels, based on quantifica-
tion of FLAG fluorescence) resulted in a similar degree of mitochon-
drial fragmentation (Figure 4, D–F). To further examine any potential 
morphological differences between exogenous expression of either 
the Drp1 WT or the single D-Box mutant constructs, both FLAG 
fluorescence and the number of mitochondrial objects (based on 
cytochrome c fluorescence) were quantified for several individual 
WT and D-Box mutant-expressing cells. These data are shown in 
Figure 4, E and F (where each data point represents an individual 
cell). Together, these data demonstrate that, like the WT protein, the 
D-Box mutant protein is fully functional in inducing mitochondrial 
FIGURE 3: Cdh1-mediated changes in mitochondrial morphology. 
(A) Cytochrome c staining of mitochondrial morphology in 
asynchronous HeLa cells transfected with HA-Cdh1 (stained for HA, 
shown in green) or untransfected (no HA staining). Images shown are 
representative of multiple independent experiments. (B) HeLa cells 
were transfected with mito-PA-GFP and pCDNA3 or pCDNA3-HA-
Cdh1. A small number of mitochondria per cell were illuminated with 
a UV laser (405 nM). The data represent the relative fluorescence of 
the UV-activated region of interest over time, and error bars represent 
the SE of the mean.
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FIGURE 4: Requirements for APC/CCdh1-mediated degradation of Drp1. (A) Ubiquitylation of in vitro–translated 
35S-Drp1 by immunopurified APC/C supplemented with recombinant Cdc20 (A) or Cdh1 (B). An N-terminal fragment of 
Cyclin B1 is shown as a positive control. (C) HeLa lysates expressing either Drp1 WT or Drp1 D-Box mutant at the 
indicated times after release from nocodazole arrest. A nonspecific band (NS) of ∼30 kDa is shown as a loading 
reference. When normalized for loading, there is an 11% increase in the Drp1 D-Box mutant relative to the WT 
construct. (D) FLAG and cytochrome c staining of mitochondrial morphology in a HeLa cells transfected with either 
FLAG-tagged pcDNA3-Drp1 WT or Flag-tagged pcDNA3-Drp1 D-Box mutant (vs. untransfected cells, showing no Flag 
staining in top panel). The maximum projection of z-stacks is shown for cytochrome c immunofluorescence. (E) Images 
were acquired and analyzed using exactly the same parameters (gain and offset values were the same), to allow for 
comparisons between image sets from the same experiment. Both FLAG fluorescence and the number of mitochondrial 
objects (based on cytochrome c fluorescence) were quantified for several individual WT and D-Box mutant-expressing 
cells, and each data point in the graph represents an individual cell. Two populations of FLAG-positive cells emerged 
during our analysis: a population with relative FLAG-fluorescence less than 30,000 U, and a population with fluorescence 
greater than 40,000 relative units. For the population with lower FLAG fluorescence, the expression of either construct 
did not correlate with the degree of mitochondrial fragmentation, whereas it did for the second population. The lack of 
correlation in the first population could reflect: decreased APC/CCdh1 activity in that subset of cells, decreased 
mitochondrial fusion to oppose Drp1-dependent fission, or a lack of tight synchronization in early G1 (for instance, that 
population of cells could be earlier in the process of mitotic exit, thus showing mitotic fragmentation that is 
independent of the exogenous Drp1). (F) Linear regression analysis of cells expressing FLAG-tagged pcDNA3-Drp1 WT 
or FLAG-tagged pcDNA3-Drp1 D-box mutant constructs (from the second population, with fluorescence greater than 
40,000 relative units). The y-axis shows fluorescence and mitochondrial object number per unit area, and the x-axis 
shows relative FLAG fluorescence. For this population of cells, the expression of both FLAG-Drp1 and FLAG-D-Box 
mutant Drp1 was correlated with increased mitochondrial object number (r = 0.74; r2 = 0.544; p = 0.02), although there 
was no significant difference in the degree of mitochondrial fragmentation caused by the two constructs (the WT vs. 
D-Box mutant).
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that the changes in mitochondrial morphol-
ogy resulting from Cdh1-mediated Drp1 
degradation correlated with cyclin E levels.
We next wanted to determine whether 
cellular metabolism was affected by mito-
chondrial fragmentation induced by the 
knockdown of Cdh1. Despite undetectable 
changes in cellular ATP levels in any of the 
cell types tested (Supplemental Figure 2), 
more detailed analysis revealed distinct 
changes in mitochondrial metabolism. Using 
a metabolomics approach, we analyzed 
steady-state levels of acyl-carnitines, metab-
olites that can be derived from several 
sources including glucose, amino acids, and 
lipids and reflect the mitochondrial acyl-
CoA pool. The acute knockdown of Cdh1 
in a G1/S-arrested HeLa cell population 
FIGURE 5: Cdh1 regulates Drp1 abundance. (A) Immunodetection of Cdh1 and Drp1 in lysates 
prepared from proliferating WT or Cdh1-null MEFs. β-tubulin is shown as a loading control.  
(B) Drp1 immunoprecipitates generated from WT or Cdh1-null MEFs were immunoblotted for 
ubiquitin. The relative abundance of Drp1-ubiquitin conjugates and Drp1 protein levels is shown. 
(C) Lysates were prepared from either WT or Cdh1-null MEFS at the indicated times after 
release from nocodazole arrest and were immunoblotted for Drp1.
FIGURE 6: Cdh1 regulates Drp1-dependent changes in mitochondrial morphology and metabolism during interphase.  
(A) Cytochrome c staining of mitochondrial morphology in G1/S-arrested cells transfected with the following siRNA 
oligonucleotides: Scrambled, Cdh1, Drp1, and both Drp1 and Cdh1. Images shown are representative of multiple 
independent experiments. (B) Blind quantification of (A) (n = 4). (C) Cyclin E immunoblotting in siRNA-transfected, 
early-G1-phase HeLa cells. (D) MS/MS-based analysis of acyl-carnitine species in G1/S-arrested HeLa cells transfected with 
the indicated siRNAs. Means of triplicate samples are shown as percent change relative to the scrambled RNAi control.
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cephaly and metabolic aberrations (Waterham et al., 2007). In 
mouse models, cells deficient in both Mfn1 and Mfn2 display frag-
mented mitochondria due to a complete lack of mitochondrial fu-
sion and show severe defects in cell growth, mitochondrial mem-
brane potential, and cellular respiration (Chen et al., 2003, 2005). 
Given these and other links between alterations in the mitochondrial 
fission/fusion balance and perturbations in cellular metabolism, it is 
interesting to note that both the Mfn2-deficient and Cdh1-deficient 
mice display similar deficiencies in both cell size and number in gi-
ant cells of the placental trophoblast (Chen et al., 2003; Garcia-
Higuera et al., 2008; Li et al., 2008). It is therefore possible that un-
balanced mitochondrial fragmentation contributes to placental 
abnormality in both of these lethal phenotypes.
Our finding that inhibition of Cdh1-mediated degradation of 
Drp1 during interphase prevents cyclin E accumulation and alters 
the profile of lipid-derived metabolites is part of growing evidence 
of a link between cellular proliferation and mitochondrial metabo-
lism. Evidence from multiple research groups suggests a “metabolic 
checkpoint” at the G1/S boundary in which several signaling path-
ways (including AMP-activated protein kinase–induced p53 activa-
tion as well as reactive oxygen species–mediated up-regulation of a 
fly cyclin-dependent kinase inhibitor homologue) converge to mod-
ulate cyclin E levels and activity (Jones et al., 2005; Mandal et al., 
2005, 2010; Owusu-Ansah et al., 2008; Mitra et al., 2009). Specifi-
cally, through its degradation of target proteins, the APC/CCdh1 
complex is emerging as an important link between the regulation of 
cell proliferation and bioenergetic status (Almeida et al., 2009; 
Herrero-Mendez et al., 2009; Colombo et al., 2010). The cross-talk 
between regulators of mitochondrial dynamics and key cell-cycle 
regulators may ensure that mitochondrial function is tightly linked 
to cell growth and proliferation. Together, these data highlight an 
exciting new area of research on the contribution of mitochondrial 
metabolism and network status to cell-cycle progression.
Through the degradation of substrates such as the Skp1/Cullin/
F-box protein (SCF) component Skp2 and the inhibitor of DNA rep-
lication geminin, the APC/CCdh1 complex regulates the proper tim-
ing of G1 and S phases. Here we describe a novel role for APC/
CCdh1 in the degradation of the mitochondrial fission protein Drp1. 
APC/CCdh1-mediated Drp1 degradation is important for maintaining 
mitochondrial network formation and metabolic function during in-
terphase, suggesting that the APC/CCdh1 complex may also regulate 
the distinct bioenergetic needs of a growing cell during synthetic 
phases of the cell cycle.
MATERIALS AND METHODS
Plasmids and protein expression
Hemagglutinin (HA)-tagged Cdh1 and Cdc20 plasmids were a gift 
from M. Pagano (New York University, New York, NY). The Drp1 ex-
pression construct was provided by A.M. van der Bliek (University of 
California, Los Angeles, CA), and was subcloned into pcDNA3 with 
a C-terminal FLAG tag. For protein production, Drp1 was first sub-
cloned into the pENTR-3C vector (Invitrogen, Carlsbad, CA) and 
then recombined into pDEST17 using LR Clonase II (Invitrogen). Re-
combinant Cdh1 protein was a gift from the Ronai Lab (Sanford-
Burnham Institute for Medical Research, La Jolla, CA). The Drp1 D-
Box mutant was prepared with a QuikChange Site-Directed 
Mutagenesis Kit (Stratagene, La Jolla, CA) using the following primer 
sequence: 5′-gtg act tgt ctt ctt gcc aaa agg gcc cct gtt aca aat g -3′.
Antibodies
The primary antibodies used for immunoblotting, immunoprecipi-
tations, and immunofluorescence were as follows: anti-Drp1 (BD 
drastically altered the steady-state levels of acyl-carnitines. Specifi-
cally, in the absence of Cdh1, there was a dramatic decrease in the 
abundance of most medium-chain acyl-carnitines and several long 
chain acyl-carnitines (unpublished observations), a profile that is con-
sistent with a block in fatty acid β-oxidation. Many of these changes 
were attenuated by dual knock-down of Drp1 and Cdh1, suggesting 
that the β-oxidation defects produced by loss of Cdh1 correlated 
with Cdh1-mediated changes in Drp1 levels (Figure 6D). For a num-
ber of the metabolites measured, loss of Drp1 alone produced 
changes in levels opposite to loss of Cdh1, again suggesting that 
perturbation of Drp1 levels, with consequent alterations in mitochon-
drial morphology, could have marked effects on cellular metabolism.
DISCUSSION
Based on the results just mentioned, APC/CCdh1-mediated degrada-
tion of Drp1 appeared to underlie the morphological changes occur-
ring in the mitochondria following cell division. It has been suggested 
that the transition from an interconnected mitochondrial network 
during interphase to a fragmented morphology during mitosis not 
only might function to physically separate mitochondria into daugh-
ter cells, but also might reflect variations in energy needs and utiliza-
tion during the cell cycle (Benard and Rossignol, 2008; Grandemange 
et al., 2009). The recent identification of retrograde signaling path-
ways from the mitochondria has uncovered a metabolic checkpoint 
at the G1/S boundary, highlighting the importance of ensuring that 
cellular proliferation is coordinated with sufficient metabolic capacity 
and proper mitochondrial function (Jones et al., 2005; Mandal 
et al., 2005, 2010; Owusu-Ansah et al., 2008; Mitra et al., 2009).
Although the relationships between morphology and mitochon-
drial metabolism are not fully understood, the decrease in levels of 
Drp1 protein temporally coincided with the return of mitochondria 
to a reticular morphology and with the significant increases in mem-
brane potential and respiration that occur during progression 
through G1 (Schieke et al., 2008). A hyperfused mitochondrial state 
at G1/S is necessary for cyclin E accumulation and cell-cycle progres-
sion, and Drp1-dependent mitochondrial fragmentation induced 
by overexpression of the novel mitochondrial inner-membrane 
protein MTGM halts cells in the S phase of the cell cycle (Mitra et al., 
2009; Zhao et al., 2009). Thus we hypothesize that APC/CCdh1-medi-
ated degradation of Drp1 (and the resulting reestablishment of the 
mitochondrial network) might function to serve the metabolic de-
mands of a proliferating cell.
Although we did not observe delays in cell-cycle progression 
due to alterations in mitochondrial morphology during our limited 
time course, it is quite possible that the increased mitochondrial 
fragmentation we observed (due to loss of Cdh1) might have cumu-
lative effects following several cell divisions. The persistently frag-
mented mitochondrial morphology that results in the absence of 
Cdh1-mediated Drp1 degradation (and the subsequent decreases 
in cyclin E and alterations in lipid-derived metabolites) may have 
cumulative deleterious effects on mitochondrial function, compara-
ble to the severe defects in cell growth, mitochondrial membrane 
potential, and cellular respiration observed in cells deficient in the 
mitochondrial fusion proteins Mfn1 and Mfn2 (which display frag-
mented mitochondria due to a complete lack of mitochondrial fu-
sion) (Chen et al., 2005).
Mitochondrial defects, such as those occurring in obesity and 
insulin resistance, are associated with decreased Mfn2 expression 
and mitochondrial network formation (Zorzano, 2009). Inhibition of 
Drp1-induced mitochondrial fission has been shown to ameliorate 
high glucose–mediated cell death (Yu et al., 2006), and a recently 
reported mutation in Drp1 resulted in lethality marked by micro-
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Transfections
Plasmid transfections were performed using Fugene 6 (Roche, 
Basel, Switzerland), according to the manufacturer’s instructions. 
siRNA oligonucleotides were transfected using Lipofectamine 
RNAiMAX (Invitrogen), according to the manufacturer’s instructions. 
For RNAi transfection/synchronization experiments, HeLa cells were 
plated at subconfluent densities and were transfected twice with 
siRNA constructs, before both the first and second thymidine block.
siRNA
siRNAs were purchased from Dharmacon (Lafayette, CO). A non-
targeting siRNA was used as a negative control (siGENOME 
siRNA #2), an ON-TARGET plus SMARTpool was used for Drp1, 
and the Cdh1 siRNA nucleotide sequence has been described 
previously (Bashir et al., 2004). To quantify changes in mitochon-
drial morphology for siRNA-transfected cells, the individual ini-
tially acquiring the images had been blinded as to with which 
RNAi oligonucleotides the cells had been transfected. Next all 
of the previously acquired images (for four total assay trials) were 
assigned random letters, and the mitochondria in each cell in the 
image were scored as fragmented, fused, or not able to be scored 
by another individual.
Immunoprecipitations
HEK 293T cells were lysed with IP buffer (50 mM Tris, pH 7.5, 
150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and Com-
plete Protease Inhibitor [Roche]), and extracts were incubated with 
HA antibody (3 μg) for 1 h at 4ºC before Protein A Sepharose was 
added. Immunoprecipitates were washed three times in IP buffer 
before loading onto SDS–PAGE gels for immunoblotting.
For Drp1-ubiquitylation experiments, WT or Cdh1 null MEFS 
were pretreated with 20 μM MG132 for 6 h prior to lysis in IP buffer. 
Lysates were quantitated by Bradford assay (Bio-Rad), and protein 
concentrations were normalized prior to incubation with Drp1-con-
jugated Protein G Sepharose for 2 h at 4ºC. Immunoprecipitates 
were washed three times in IP buffer prior to SDS–PAGE and immu-
noblotting.
Preparation of recombinant proteins and pulldowns
pDEST17-Drp1 was generated from pENTR-3C-Drp1, according 
to the manufacturer’s instructions (Invitrogen). pDEST17-Drp1 
was then transformed into BL21-AI cells (Invitrogen), and His-
Drp1 was purified using Ni-affinity chromatography (Ni-NTA 
agarose; Qiagen, Germantown, MD). Ni-bound His-Drp1 beads 
were washed first in wash buffer containing 10 mM HEPES, pH 
7.5, 500 mM NaCl with 0.02% Triton X-100 and then in wash 
buffer without Triton X-100. Control nickel beards were pre-
blocked in 0.125 M histidine. Both sets of bead (control nickel 
and Ni-bound His-Drp1) were washed in IP buffer and then incu-
bated with cell lysates (lysed in IP buffer) for 2 h at 4ºC. The 
beads were washed three times in IP buffer before being loaded 
onto SDS–PAGE gels for immunoblotting. MBP and MBP-Emi2 
were produced as previously described (Wu et al., 2007), except 
that amylose resin (New England Niolabs, Ipswich, MA) was 
used and proteins were eluted with 20 mM maltose.
Immunofluorescence and microscopy
On the basis of our observations of mitochondrial morphology in 
HeLa cells exiting mitosis, we noted a discrepancy in the timing of 
mitochondrial elongation and network establishment between cells 
exiting release from a nocodazole arrest and cells that had been ar-
rested at the G1/S border and allowed to progress through mitosis 
in absence of nocodazole. Specifically, nocodazole-arrested cells 
Transduction Laboratories, Franklin Lakes, NJ); Phospho-Histone 
H3 (Cell Signaling Technology, Danvers, MA); anti-actin, anti-HA, 
anti-Cdc27, anti-Cyclin E, and Cyclin B1 (monoclonal and poly-
clonal) (Santa Cruz Biotechnology, Santa Cruz, CA); anti-Cdh1 
(Thermo Scientific, Kalamazoo, MI); anti-FLAG (polyclonal; Sigma, 
St. Louis, MO); and anti-cytochrome c (BD PharMingen, Sparks, 
MD). The Mfn2 antibody was a gift from Richard Youle (National 
Institute of Neurological Disorders and Stroke, Bethesda, MD). 
AlexaFluor (Invitrogen) and IR-Dye (LI-COR Biosciences, Lincoln, 
NE) secondary antibodies were used for immunofluorescence or 
for immunoblotting with the LI-COR Imaging System, or horserad-
ish peroxidase–conjugated antibodies (from Promega, Madison, 
WI, and Dako, Carpenteria, CA) were used with an ECL-Plus detec-
tion system (Amersham Biosciences, Piscataway, NJ).
For immunofluorescence, cells were stained with the following 
primary antibodies: anti-FLAG (Sigma), anti-HA (Santa Cruz Biotech-
nology), or anti-cytochrome c (BD PharMingen). Following phos-
phate-buffered saline (PBS) washes, cells were next incubated with 
secondary antibodies, including goat anti–rabbit Alexa 488, goat 
anti–mouse Alexa 594, or goat anti–rabbit Alexa 561 (Molecular 
Probes, Eugene, OR, or Invitrogen).
Cell culture and synchronization
HeLa, HeLa S3, and HEK 293T cells were grown in DMEM with 
10% fetal bovine serum (FBS). For double thymidine block experi-
ments, HeLa and HeLa S3 cells were synchronized by sequential 
incubations with 2.5 mM thymidine and either released into me-
dium containing nocodazole at 40 ng/ml (for G1/S release experi-
ments) or analyzed during the second thymidine block (for mito-
chondrial morphology and metabolomics). To generate early G1 
cells for immunofluorescence, cells were examined 14.5–16 h fol-
lowing release from the second thymidine arrest. For nocodazole 
release experiments, HeLa and HeLa S3 cells were blocked in 
medium containing nocodazole 40 ng/ml for 16–17 h. Nonadher-
ent cells were washed three times in PBS and released into com-
plete medium. At the indicated times after release, adherent cells 
were harvested for Western blotting. For nocodazole release ex-
periments in Cdh1 MEFS, cells were synchronized using a single 
thymidine block (2.5 mM) and were then released into medium 
containing nocodazole at 80 ng/ml for 17 h. Cells were released 
and harvested as described earlier in text. In vitro mitotic exit as-
says were performed as previously described (Wu et al., 2009). For 
Western blotting, cells were lysed in cold RIPA buffer (50 mM Tris, 
pH 7.4, 1% Nonidet P-40 [NP-40], 0.25% sodium deoxycholate, 
1 mM EDTA, 0.1% SDS, 150 mM NaCl supplemented with apro-
tonin and leupeptin at 10 mg/ml, and 1 mM sodium vanadate). 
Lysate concentrations were determined by Bradford assay 
(Bio-Rad, Hercules, CA), and concentrations were normalized be-
fore loading onto SDS–PAGE gels. Proteasome inhibitors were 
used at the following concentrations: lactacystin (Sigma, St. Louis, 
MO) at 30 μM for 6 h; MG132 (Calbiochem, San Diego, CA) at 
20 μM for 5 h or epoxomicin (Calbiochem) at 2.5 μM for 11 h.
Cdh1 WT and null MEFS were provided by the Malumbres Lab 
(The Spanish National Cancer Research Center [CNIO], Madrid), 
and were cultured in DMEM supplemented with 10% FBS and 2 mM 
l-glutamine.
In vitro APC assay
The APC assay was performed as previously described (Wu et al., 
2007) with the following modifications: immunoprecipitated Xeno-
pus APC was incubated with either Cdc20 or Cdh1 at room tem-
perature for 1 h, and then 35S-labeled human Drp1 was added in the 
presence of recombinant E1, E2, and ATP.
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normalized protein concentrations) for targeted analysis of acyl-car-
nitine levels by tandem mass spectrometry (MS/MS) as previously 
described (An et al., 2004; Newgard et al., 2009).
ATP assay
ATP levels in siRNA-transfected HeLa cells, arrested at the G1/S 
boundary, are shown in the Supplemental Materials and Methods. 
Equal cells numbers were harvested following the second thymidine 
incubation, and relative bioluminescence was measured for tripli-
cate samples using the ATP Bioluminescence Assay Kit CLS II 
(Roche).
did not show mitochondrial network formation until 6 h following 
release, whereas reformation of the network occurred quickly during 
mitotic exit in our experiments using unperturbed live cells, consis-
tent with previous reports. This discrepancy can likely be attributed 
to the importance of microtubules in maintaining mitochondrial 
morphology (Frederick and Shaw, 2007). Thus, for synchronized cell 
experiments, we examined mitochondrial morphology either at the 
G1/S boundary or 14.5 h following release from double thymidine 
arrest (early G1).
Cells were fixed in 4% formaldehyde for 10 min, permeabilized 
with 0.5% Triton X-100 for 5 min, and then blocked with 5% goat 
serum before immunostaining. Mitochondrial morphology was ana-
lyzed using an Olympus (Center Valley, PA) IX-70 spinning disk con-
focal or a Leica (Buffalo Grove, IL) SP5 confocal microscope. For the 
spinning disk confocal, the 100×/1.35 oil objective was used with 
488-nm laser lines for excitation with an Hamamatsu (Hamamatsu 
City, Japan) ORCA ER CCD camera, and the system was controlled 
by MetaMorph (Molecular Devices, Sunnyvale, CA). For the Leica 
SP5 confocal, the 100×/1.4 oil objective was used with 488-, 561-, 
and 594-nm laser lines for excitation.
For determination of FLAG fluorescence and mitochondrial 
object numbers, early G1 cells (fixed at 14.5 h following release 
from a double thymidine block) were imaged using a Leica SP5 
confocal microscope. The images were acquired using the same 
parameters (100×/1.4 oil immersion objective with 488- and 
561-nm laser lines for excitation, with the same gain and offset 
values used for each image) to allow for comparison of images. 
Image deconvolution was performed using Huygens Essential 
software (Scientific Volume Imaging, Hilversum, The Nether-
lands), using the batch processor with a signal-to-noise ratio of 
8 and a maximum of 40 iterations. The output was 16-bit, un-
scaled images to allow the comparison of pixel values across 
images (as described in Howell et al., 2009). Cytochrome c–pos-
itive objects were analyzed using the same threshold values (to 
control for background), using the Huygens Object Analyzer 
program. For quantification of FLAG fluorescence, maximum 
projection of all the z-stacks was generated using Leica Micro-
systems LAS AF Software. Cellular area was determined using 
MetaMorph software, and values are shown as the number of 
cytochrome c–positive objects per unit area.
To measure mitochondrial fusion using the diffusion of photoac-
tivatable mito-GFP following photoactivation, HeLa cells were trans-
fected with mito-PA-GFP and pCDNA3 or pCDNA3-HA-CDH1 at a 
1:6 mg ratio (mito-PA-GFP:pCDNA3) for 18 h using Fugene 6 (Roche) 
in 30-mm coverslip dishes (MatTek, Ashland, MA). Cell medium was 
supplemented with 25 mM HEPES, pH 7.4. The cells were then visu-
alized on a Leica SP5 confocal microscope at 37ºC. A small number 
of mitochondria per cell were illuminated with a UV laser (405 nM) 
for 3 s. Images were then taken every 15 s for 8 min. The data rep-
resent the relative fluorescence of the UV-activated region of inter-
est over time. The data are presented as a percentage of the fluo-
rescence at time zero. Each data point represents averaged relative 
fluorescence measurements at each time point from at least 75 re-
gions of interest from transfected cells. Error bars represent the SE 
of the mean.
Acyl-carnitine and metabolic analysis
HeLa cells that had been transfected with siRNA were incubated 
with 1 μM l-carnitine for 20–22 h during the final thymidine block. 
Sterile water was added to harvested cell pellets, and cells were 
lysed by sonication. Protein concentrations were determined by 
Bradford assay (Bio-Rad), and triplicate samples were prepared (with 
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